These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24703118)

  • 41. Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.
    Framme C; Sachs HG; Flucke B; Theisen-Kunde D; Birngruber R
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5437-46. PubMed ID: 17122134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland.
    Huang Z; Haider MA; Kraft S; Chen Q; Blanc D; Wilson BC; Hetzel FW
    Lasers Surg Med; 2006 Aug; 38(7):672-81. PubMed ID: 16799982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland.
    Pantelides ML; Whitehurst C; Moore JV; King TA; Blacklock NJ
    J Urol; 1990 Feb; 143(2):398-401. PubMed ID: 2299739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Photodynamic therapy with WST09 (Tookad): quantitative studies in normal colon and transplanted tumours.
    Woodhams JH; MacRobert AJ; Novelli M; Bown SG
    Int J Cancer; 2006 Jan; 118(2):477-82. PubMed ID: 16052532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease.
    Moore CM; Emberton M; Bown SG
    Lasers Surg Med; 2011 Sep; 43(7):768-75. PubMed ID: 22057504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins.
    Brandis A; Mazor O; Neumark E; Rosenbach-Belkin V; Salomon Y; Scherz A
    Photochem Photobiol; 2005; 81(4):983-93. PubMed ID: 15839743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morbidity of focal therapy in the treatment of localized prostate cancer.
    Barret E; Ahallal Y; Sanchez-Salas R; Galiano M; Cosset JM; Validire P; Macek P; Durand M; Prapotnich D; Rozet F; Cathelineau X
    Eur Urol; 2013 Apr; 63(4):618-22. PubMed ID: 23265382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan® and Fospeg in a human prostate cancer cell line.
    Petri A; Yova D; Alexandratou E; Kyriazi M; Rallis M
    Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):344-54. PubMed ID: 23200016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perfusion, oxygenation status and growth of experimental tumors upon photodynamic therapy with Pd-bacteriopheophorbide.
    Kelleher DK; Thews O; Scherz A; Salomon Y; Vaupel P
    Int J Oncol; 2004 Jun; 24(6):1505-11. PubMed ID: 15138594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Photodynamic therapy and prostate cancer].
    Colin P; Estevez JP; Betrouni N; Ouzzane A; Puech P; Leroy X; Biserte J; Villers A; Mordon S
    Prog Urol; 2011 Feb; 21(2):85-92. PubMed ID: 21296274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.
    Chang SC; Buonaccorsi G; MacRobert A; Bown SG
    Int J Cancer; 1996 Aug; 67(4):555-62. PubMed ID: 8759616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: An in vitro study in 2D and 3D prostate cancer models.
    Martinez de Pinillos Bayona A; Woodhams JH; Pye H; Hamoudi RA; Moore CM; MacRobert AJ
    Cancer Lett; 2017 May; 393():68-75. PubMed ID: 28223166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel photodynamic therapy for drug-resistant prostate cancer cells using porphyrus envelope as a novel photosensitizer.
    Yamauchi M; Honda N; Hazama H; Tachikawa S; Nakamura H; Kaneda Y; Awazu K
    Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):48-54. PubMed ID: 24629697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contrast enhanced ultrasound imaging can predict vascular-targeted photodynamic therapy induced tumor necrosis in small animals.
    Cornelis FH; Kim K; Durack JC; Jebiwott S; Scherz A; Srimathveeravalli G; Coleman JA
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():165-168. PubMed ID: 28887222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Focal therapy in the treatment of localised prostate cancer: primum non nocere.
    Challacombe BJ; Murphy DG
    Eur Urol; 2013 Apr; 63(4):623-4; discussion 625-6. PubMed ID: 23290301
    [No Abstract]   [Full Text] [Related]  

  • 56. Re: Padeliporfin Vascular-Targeted Photodynamic Therapy versus Active Surveillance in Men with Low-Risk Prostate Cancer (CLIN1001 PCM301): An Open-Label, Phase 3, Randomised Controlled Trial.
    Taneja SS
    J Urol; 2017 Aug; 198(2):255-257. PubMed ID: 29370650
    [No Abstract]   [Full Text] [Related]  

  • 57. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI.
    Gross S; Gilead A; Scherz A; Neeman M; Salomon Y
    Nat Med; 2003 Oct; 9(10):1327-31. PubMed ID: 14502284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison between endothelial and tumor cells in the response to verteporfin-photodynamic therapy and a PI3K pathway inhibitor.
    Fateye B; Wan A; Yang X; Myers K; Chen B
    Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):19-26. PubMed ID: 25636781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro.
    Gyenge EB; Hiestand S; Graefe S; Walt H; Maake C
    Photodiagnosis Photodyn Ther; 2011 Jun; 8(2):86-96. PubMed ID: 21497299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.